Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Herpes Simplex Virus Infection Treatment Market Growth (Status and Outlook) 2022-2028

  • LP 4859150
  • 111 Pages
  • February 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Herpes Simplex Virus Infection Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Herpes Simplex Virus Infection Treatment market size is USD million in 2022 from USD 4443.3 million in 2021, with a change of % between 2021 and 2022. The global Herpes Simplex Virus Infection Treatment market size will reach USD 5330.6 million in 2028, growing at a CAGR of 2.6% over the analysis period.

The United States Herpes Simplex Virus Infection Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Herpes Simplex Virus Infection Treatment market, reaching US$ million by the year 2028. As for the Europe Herpes Simplex Virus Infection Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Herpes Simplex Virus Infection Treatment players cover F. Hoffmann-La Roche Ltd, Sanofi, Teva Pharmaceuticals Inc, and Merck & Co., Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Simplex Virus Infection Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

By Type

Herpes Simplex Virus-1 (HSV-1) Infection

Herpes Simplex Virus-2 (HSV-2) Infection

HSV1 & HSV2 Co-infection

By Route of Administration

Oral

Parenteral

By Drug Molecule

Small Molecule

Vaccine

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

F. Hoffmann-La Roche Ltd

Sanofi

Teva Pharmaceuticals Inc

Merck & Co., Inc

Apotex Inc

Viatris

Epi Health LLC

Zydus Pharmaceuticals

GlaxoSmithKline LLC

Carlsbad Tech

Avet Pharmaceuticals Inc

Glenmark Pharmaceuticals

Fresenius Kabi

Agenus, Inc

Maruho Co. Ltd

AiCuris Anti-infective Cures GmbH

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Herpes Simplex Virus Infection Treatment Market Size 2017-2028

2.1.2 Herpes Simplex Virus Infection Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Herpes Simplex Virus Infection Treatment Segment by Type

2.2.1 Herpes Simplex Virus-1 (HSV-1) Infection

2.2.2 Herpes Simplex Virus-2 (HSV-2) Infection

2.2.3 HSV1 & HSV2 Co-infection

2.3 Herpes Simplex Virus Infection Treatment Market Size by Type

2.3.1 Herpes Simplex Virus Infection Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)

2.4 Herpes Simplex Virus Infection Treatment Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Herpes Simplex Virus Infection Treatment Market Size by Application

2.5.1 Herpes Simplex Virus Infection Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)

3 Herpes Simplex Virus Infection Treatment Market Size by Player

3.1 Herpes Simplex Virus Infection Treatment Market Size Market Share by Players

3.1.1 Global Herpes Simplex Virus Infection Treatment Revenue by Players (2020-2022)

3.1.2 Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Herpes Simplex Virus Infection Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Herpes Simplex Virus Infection Treatment by Regions

4.1 Herpes Simplex Virus Infection Treatment Market Size by Regions (2017-2022)

4.2 Americas Herpes Simplex Virus Infection Treatment Market Size Growth (2017-2022)

4.3 APAC Herpes Simplex Virus Infection Treatment Market Size Growth (2017-2022)

4.4 Europe Herpes Simplex Virus Infection Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Herpes Simplex Virus Infection Treatment Market Size by Country (2017-2022)

5.2 Americas Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022)

5.3 Americas Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Herpes Simplex Virus Infection Treatment Market Size by Region (2017-2022)

6.2 APAC Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022)

6.3 APAC Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Herpes Simplex Virus Infection Treatment by Country (2017-2022)

7.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022)

7.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Herpes Simplex Virus Infection Treatment by Region (2017-2022)

8.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Herpes Simplex Virus Infection Treatment Market Forecast

10.1 Global Herpes Simplex Virus Infection Treatment Forecast by Regions (2023-2028)

10.1.1 Global Herpes Simplex Virus Infection Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Herpes Simplex Virus Infection Treatment Forecast

10.1.3 APAC Herpes Simplex Virus Infection Treatment Forecast

10.1.4 Europe Herpes Simplex Virus Infection Treatment Forecast

10.1.5 Middle East & Africa Herpes Simplex Virus Infection Treatment Forecast

10.2 Americas Herpes Simplex Virus Infection Treatment Forecast by Country (2023-2028)

10.2.1 United States Herpes Simplex Virus Infection Treatment Market Forecast

10.2.2 Canada Herpes Simplex Virus Infection Treatment Market Forecast

10.2.3 Mexico Herpes Simplex Virus Infection Treatment Market Forecast

10.2.4 Brazil Herpes Simplex Virus Infection Treatment Market Forecast

10.3 APAC Herpes Simplex Virus Infection Treatment Forecast by Region (2023-2028)

10.3.1 China Herpes Simplex Virus Infection Treatment Market Forecast

10.3.2 Japan Herpes Simplex Virus Infection Treatment Market Forecast

10.3.3 Korea Herpes Simplex Virus Infection Treatment Market Forecast

10.3.4 Southeast Asia Herpes Simplex Virus Infection Treatment Market Forecast

10.3.5 India Herpes Simplex Virus Infection Treatment Market Forecast

10.3.6 Australia Herpes Simplex Virus Infection Treatment Market Forecast

10.4 Europe Herpes Simplex Virus Infection Treatment Forecast by Country (2023-2028)

10.4.1 Germany Herpes Simplex Virus Infection Treatment Market Forecast

10.4.2 France Herpes Simplex Virus Infection Treatment Market Forecast

10.4.3 UK Herpes Simplex Virus Infection Treatment Market Forecast

10.4.4 Italy Herpes Simplex Virus Infection Treatment Market Forecast

10.4.5 Russia Herpes Simplex Virus Infection Treatment Market Forecast

10.5 Middle East & Africa Herpes Simplex Virus Infection Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Herpes Simplex Virus Infection Treatment Market Forecast

10.5.2 South Africa Herpes Simplex Virus Infection Treatment Market Forecast

10.5.3 Israel Herpes Simplex Virus Infection Treatment Market Forecast

10.5.4 Turkey Herpes Simplex Virus Infection Treatment Market Forecast

10.5.5 GCC Countries Herpes Simplex Virus Infection Treatment Market Forecast

10.6 Global Herpes Simplex Virus Infection Treatment Forecast by Type (2023-2028)

10.7 Global Herpes Simplex Virus Infection Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 F. Hoffmann-La Roche Ltd

11.1.1 F. Hoffmann-La Roche Ltd Company Information

11.1.2 F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Product Offered

11.1.3 F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 F. Hoffmann-La Roche Ltd Main Business Overview

11.1.5 F. Hoffmann-La Roche Ltd Latest Developments

11.2 Sanofi

11.2.1 Sanofi Company Information

11.2.2 Sanofi Herpes Simplex Virus Infection Treatment Product Offered

11.2.3 Sanofi Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sanofi Main Business Overview

11.2.5 Sanofi Latest Developments

11.3 Teva Pharmaceuticals Inc

11.3.1 Teva Pharmaceuticals Inc Company Information

11.3.2 Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product Offered

11.3.3 Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Teva Pharmaceuticals Inc Main Business Overview

11.3.5 Teva Pharmaceuticals Inc Latest Developments

11.4 Merck & Co., Inc

11.4.1 Merck & Co., Inc Company Information

11.4.2 Merck & Co., Inc Herpes Simplex Virus Infection Treatment Product Offered

11.4.3 Merck & Co., Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Merck & Co., Inc Main Business Overview

11.4.5 Merck & Co., Inc Latest Developments

11.5 Apotex Inc

11.5.1 Apotex Inc Company Information

11.5.2 Apotex Inc Herpes Simplex Virus Infection Treatment Product Offered

11.5.3 Apotex Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Apotex Inc Main Business Overview

11.5.5 Apotex Inc Latest Developments

11.6 Viatris

11.6.1 Viatris Company Information

11.6.2 Viatris Herpes Simplex Virus Infection Treatment Product Offered

11.6.3 Viatris Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Viatris Main Business Overview

11.6.5 Viatris Latest Developments

11.7 Epi Health LLC

11.7.1 Epi Health LLC Company Information

11.7.2 Epi Health LLC Herpes Simplex Virus Infection Treatment Product Offered

11.7.3 Epi Health LLC Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Epi Health LLC Main Business Overview

11.7.5 Epi Health LLC Latest Developments

11.8 Zydus Pharmaceuticals

11.8.1 Zydus Pharmaceuticals Company Information

11.8.2 Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Product Offered

11.8.3 Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Zydus Pharmaceuticals Main Business Overview

11.8.5 Zydus Pharmaceuticals Latest Developments

11.9 GlaxoSmithKline LLC

11.9.1 GlaxoSmithKline LLC Company Information

11.9.2 GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Product Offered

11.9.3 GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 GlaxoSmithKline LLC Main Business Overview

11.9.5 GlaxoSmithKline LLC Latest Developments

11.10 Carlsbad Tech

11.10.1 Carlsbad Tech Company Information

11.10.2 Carlsbad Tech Herpes Simplex Virus Infection Treatment Product Offered

11.10.3 Carlsbad Tech Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Carlsbad Tech Main Business Overview

11.10.5 Carlsbad Tech Latest Developments

11.11 Avet Pharmaceuticals Inc

11.11.1 Avet Pharmaceuticals Inc Company Information

11.11.2 Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product Offered

11.11.3 Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Avet Pharmaceuticals Inc Main Business Overview

11.11.5 Avet Pharmaceuticals Inc Latest Developments

11.12 Glenmark Pharmaceuticals

11.12.1 Glenmark Pharmaceuticals Company Information

11.12.2 Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Product Offered

11.12.3 Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Glenmark Pharmaceuticals Main Business Overview

11.12.5 Glenmark Pharmaceuticals Latest Developments

11.13 Fresenius Kabi

11.13.1 Fresenius Kabi Company Information

11.13.2 Fresenius Kabi Herpes Simplex Virus Infection Treatment Product Offered

11.13.3 Fresenius Kabi Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Fresenius Kabi Main Business Overview

11.13.5 Fresenius Kabi Latest Developments

11.14 Agenus, Inc

11.14.1 Agenus, Inc Company Information

11.14.2 Agenus, Inc Herpes Simplex Virus Infection Treatment Product Offered

11.14.3 Agenus, Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Agenus, Inc Main Business Overview

11.14.5 Agenus, Inc Latest Developments

11.15 Maruho Co. Ltd

11.15.1 Maruho Co. Ltd Company Information

11.15.2 Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Product Offered

11.15.3 Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Maruho Co. Ltd Main Business Overview

11.15.5 Maruho Co. Ltd Latest Developments

11.16 AiCuris Anti-infective Cures GmbH

11.16.1 AiCuris Anti-infective Cures GmbH Company Information

11.16.2 AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Product Offered

11.16.3 AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 AiCuris Anti-infective Cures GmbH Main Business Overview

11.16.5 AiCuris Anti-infective Cures GmbH Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Herpes Simplex Virus Infection Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Herpes Simplex Virus-1 (HSV-1) Infection

Table 3. Major Players of Herpes Simplex Virus-2 (HSV-2) Infection

Table 4. Major Players of HSV1 & HSV2 Co-infection

Table 5. Herpes Simplex Virus Infection Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)

Table 8. Herpes Simplex Virus Infection Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)

Table 11. Global Herpes Simplex Virus Infection Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Player (2020-2022)

Table 13. Herpes Simplex Virus Infection Treatment Key Players Head office and Products Offered

Table 14. Herpes Simplex Virus Infection Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Herpes Simplex Virus Infection Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Regions (2017-2022)

Table 19. Americas Herpes Simplex Virus Infection Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Herpes Simplex Virus Infection Treatment Market Size Market Share by Country (2017-2022)

Table 21. Americas Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)

Table 23. Americas Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)

Table 25. APAC Herpes Simplex Virus Infection Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Region (2017-2022)

Table 27. APAC Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)

Table 29. APAC Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)

Table 31. Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Country (2017-2022)

Table 33. Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)

Table 35. Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Herpes Simplex Virus Infection Treatment

Table 44. Key Market Challenges & Risks of Herpes Simplex Virus Infection Treatment

Table 45. Key Industry Trends of Herpes Simplex Virus Infection Treatment

Table 46. Global Herpes Simplex Virus Infection Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Herpes Simplex Virus Infection Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Herpes Simplex Virus Infection Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Herpes Simplex Virus Infection Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Herpes Simplex Virus Infection Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Herpes Simplex Virus Infection Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 52. F. Hoffmann-La Roche Ltd Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 53. F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Product Offered

Table 54. F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. F. Hoffmann-La Roche Ltd Main Business

Table 56. F. Hoffmann-La Roche Ltd Latest Developments

Table 57. Sanofi Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 58. Sanofi Herpes Simplex Virus Infection Treatment Product Offered

Table 59. Sanofi Main Business

Table 60. Sanofi Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Sanofi Latest Developments

Table 62. Teva Pharmaceuticals Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 63. Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product Offered

Table 64. Teva Pharmaceuticals Inc Main Business

Table 65. Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Teva Pharmaceuticals Inc Latest Developments

Table 67. Merck & Co., Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 68. Merck & Co., Inc Herpes Simplex Virus Infection Treatment Product Offered

Table 69. Merck & Co., Inc Main Business

Table 70. Merck & Co., Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Merck & Co., Inc Latest Developments

Table 72. Apotex Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 73. Apotex Inc Herpes Simplex Virus Infection Treatment Product Offered

Table 74. Apotex Inc Main Business

Table 75. Apotex Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Apotex Inc Latest Developments

Table 77. Viatris Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 78. Viatris Herpes Simplex Virus Infection Treatment Product Offered

Table 79. Viatris Main Business

Table 80. Viatris Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Viatris Latest Developments

Table 82. Epi Health LLC Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 83. Epi Health LLC Herpes Simplex Virus Infection Treatment Product Offered

Table 84. Epi Health LLC Main Business

Table 85. Epi Health LLC Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Epi Health LLC Latest Developments

Table 87. Zydus Pharmaceuticals Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 88. Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Product Offered

Table 89. Zydus Pharmaceuticals Main Business

Table 90. Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Zydus Pharmaceuticals Latest Developments

Table 92. GlaxoSmithKline LLC Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 93. GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Product Offered

Table 94. GlaxoSmithKline LLC Main Business

Table 95. GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. GlaxoSmithKline LLC Latest Developments

Table 97. Carlsbad Tech Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 98. Carlsbad Tech Herpes Simplex Virus Infection Treatment Product Offered

Table 99. Carlsbad Tech Main Business

Table 100. Carlsbad Tech Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Carlsbad Tech Latest Developments

Table 102. Avet Pharmaceuticals Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 103. Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product Offered

Table 104. Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Avet Pharmaceuticals Inc Main Business

Table 106. Avet Pharmaceuticals Inc Latest Developments

Table 107. Glenmark Pharmaceuticals Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 108. Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Product Offered

Table 109. Glenmark Pharmaceuticals Main Business

Table 110. Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Glenmark Pharmaceuticals Latest Developments

Table 112. Fresenius Kabi Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 113. Fresenius Kabi Herpes Simplex Virus Infection Treatment Product Offered

Table 114. Fresenius Kabi Main Business

Table 115. Fresenius Kabi Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Fresenius Kabi Latest Developments

Table 117. Agenus, Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 118. Agenus, Inc Herpes Simplex Virus Infection Treatment Product Offered

Table 119. Agenus, Inc Main Business

Table 120. Agenus, Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Agenus, Inc Latest Developments

Table 122. Maruho Co. Ltd Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 123. Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Product Offered

Table 124. Maruho Co. Ltd Main Business

Table 125. Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. Maruho Co. Ltd Latest Developments

Table 127. AiCuris Anti-infective Cures GmbH Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors

Table 128. AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Product Offered

Table 129. AiCuris Anti-infective Cures GmbH Main Business

Table 130. AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. AiCuris Anti-infective Cures GmbH Latest Developments

List of Figures

Figure 1. Herpes Simplex Virus Infection Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Type in 2021

Figure 7. Herpes Simplex Virus Infection Treatment in Hospital Pharmacies

Figure 8. Global Herpes Simplex Virus Infection Treatment Market: Hospital Pharmacies (2017-2022) & ($ Millions)

Figure 9. Herpes Simplex Virus Infection Treatment in Retail Pharmacies

Figure 10. Global Herpes Simplex Virus Infection Treatment Market: Retail Pharmacies (2017-2022) & ($ Millions)

Figure 11. Herpes Simplex Virus Infection Treatment in Online Pharmacies

Figure 12. Global Herpes Simplex Virus Infection Treatment Market: Online Pharmacies (2017-2022) & ($ Millions)

Figure 13. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021

Figure 14. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Player in 2021

Figure 15. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Herpes Simplex Virus Infection Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Herpes Simplex Virus Infection Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Herpes Simplex Virus Infection Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Herpes Simplex Virus Infection Treatment Value Market Share by Country in 2021

Figure 21. Americas Herpes Simplex Virus Infection Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021

Figure 23. United States Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021

Figure 29. China Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450